The Klinique Medical Clinic PCL (BKK:KLINIQ)
Thailand · Delayed Price · Currency is THB 28.50
0.00 (0.00%)
Sep 4, 2026, 4:35 PM ICT
BKK:KLINIQ Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 4,105 | 3,556 | 2,983 | 2,285 | 1,639 | 949.93 |
| 4,105 | 3,556 | 2,983 | 2,285 | 1,639 | 949.93 | |
Revenue Growth | 25.96% | 19.22% | 30.55% | 39.41% | 72.54% | -5.06% |
Cost of Revenue | 2,016 | 1,760 | 1,440 | 1,050 | 716.07 | 391.16 |
Gross Profit | 2,088 | 1,796 | 1,543 | 1,235 | 922.97 | 558.77 |
Selling, General & Admin | 1,548 | 1,333 | 1,154 | 903.07 | 674.28 | 407.68 |
Other Operating Expenses | -18.49 | -13.44 | -9.54 | -13.2 | -7.06 | -2.15 |
Operating Expenses | 1,530 | 1,319 | 1,144 | 889.88 | 667.22 | 405.53 |
Operating Income | 558.46 | 477.21 | 398.58 | 345.16 | 255.75 | 153.24 |
Interest Expense | -27.23 | -26.34 | -23.9 | -15.1 | -10.66 | -4.32 |
Interest & Investment Income | 7.42 | 10.17 | 16.25 | 20.17 | 1.11 | 0.06 |
Pretax Income | 538.65 | 461.05 | 390.92 | 350.22 | 246.2 | 148.98 |
Income Tax Expense | 115.89 | 97 | 68.73 | 61.6 | 40.71 | 19.73 |
Earnings From Continuing Operations | 422.77 | 364.05 | 322.19 | 288.62 | 205.49 | 129.26 |
Minority Interest in Earnings | -0.47 | -0.35 | - | - | - | - |
Net Income | 422.3 | 363.7 | 322.19 | 288.62 | 205.49 | 129.26 |
Net Income to Common | 422.3 | 363.7 | 322.19 | 288.62 | 205.49 | 129.26 |
Net Income Growth | 21.75% | 12.88% | 11.63% | 40.45% | 58.98% | -10.67% |
Shares Outstanding (Basic) | 220 | 220 | 220 | 220 | 170 | 160 |
Shares Outstanding (Diluted) | 220 | 220 | 220 | 220 | 170 | 160 |
Shares Change | - | - | - | 29.64% | 6.06% | - |
EPS (Basic) | 1.92 | 1.65 | 1.46 | 1.31 | 1.21 | 0.81 |
EPS (Diluted) | 1.92 | 1.65 | 1.46 | 1.31 | 1.21 | 0.81 |
EPS Growth | 21.75% | 12.88% | 11.63% | 8.34% | 49.89% | -10.67% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 474.72 | 360.62 | -19.7 | 19.39 | 182.17 | 165.64 |
Free Cash Flow Per Share | 2.16 | 1.64 | -0.09 | 0.09 | 1.07 | 1.03 |
Dividend Per Share | 1.630 | 1.450 | 1.400 | 1.300 | 0.500 | 0.356 |
Dividend Growth | 12.41% | 3.57% | 7.69% | 160.00% | 40.33% | 18.77% |
Gross Margin | 50.88% | 50.51% | 51.71% | 54.05% | 56.31% | 58.82% |
Operating Margin | 13.61% | 13.42% | 13.36% | 15.10% | 15.60% | 16.13% |
Profit Margin | 10.29% | 10.23% | 10.80% | 12.63% | 12.54% | 13.61% |
Free Cash Flow Margin | 11.56% | 10.14% | -0.66% | 0.85% | 11.11% | 17.44% |
EBITDA | 689.85 | 662.88 | 553.05 | 539.76 | 329 | 205.17 |
EBITDA Margin | 16.81% | 18.64% | 18.54% | 23.62% | 20.07% | 21.60% |
D&A For EBITDA | 131.39 | 185.67 | 154.47 | 194.61 | 73.26 | 51.93 |
EBIT | 558.46 | 477.21 | 398.58 | 345.16 | 255.75 | 153.24 |
EBIT Margin | 13.61% | 13.42% | 13.36% | 15.10% | 15.60% | 16.13% |
Effective Tax Rate | 21.51% | 21.04% | 17.58% | 17.59% | 16.54% | 13.24% |